Page last updated: 2024-09-03

imatinib mesylate and Anastomotic Leak

imatinib mesylate has been researched along with Anastomotic Leak in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baia, M; Bastiaannet, E; Desar, IME; Farag, S; Gelderblom, H; Gronchi, A; Hohenberger, P; IJzerman, NS; Jones, RL; Martin-Broto, J; Mohammadi, M; Oosten, AW; Reyners, AKL; Rutkowski, P; Schöffski, P; Schrage, Y; Steeghs, N; van Sandick, JW; Vassos, N	1

Other Studies

1 other study(ies) available for imatinib mesylate and Anastomotic Leak

Article	Year
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:8 Topics: Aged; Anastomotic Leak; Antineoplastic Agents; Biopsy, Fine-Needle; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Europe; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Margins of Excision; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Metastasis; Plastic Surgery Procedures; Postoperative Complications; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Tumor Burden	2021

Article

Year

Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:8

Topics: Aged; Anastomotic Leak; Antineoplastic Agents; Biopsy, Fine-Needle; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Europe; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Margins of Excision; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Metastasis; Plastic Surgery Procedures; Postoperative Complications; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Tumor Burden

2021